CDX2 and colorectal cancer: Further studies found that intestinal specific transcription factor CDX2 mediated by RNA interference (RNAi) is a trans-activator of growth-promoting gene expression in colorectal cancer, suggesting that MS4A12 may be a potential therapeutic target for colorectal cancer [54].